Published in J Heart Lung Transplant on September 01, 2005
Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) (2008) 1.15
Bone marrow-derived cell therapy in chagasic cardiac disease: a review of pre-clinical and clinical results. Cardiovasc Diagn Ther (2012) 0.75
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol (2006) 8.27
Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66
Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med (2010) 5.59
Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med (2003) 5.43
Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med (2013) 5.36
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation (2007) 5.05
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol (2002) 4.94
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol (2005) 4.29
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol (2006) 3.91
In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation (2005) 3.23
Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol (2007) 2.95
Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol (2005) 2.65
Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation (2008) 2.64
Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation (2008) 2.52
Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol (2008) 2.45
Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng (2005) 2.23
Exercise-induced ST-segment elevation in ECG lead aVR is a useful indicator of significant left main or ostial LAD coronary artery stenosis. JACC Cardiovasc Imaging (2011) 2.21
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. Blood (2012) 2.14
Progress in tissue engineering. Sci Am (2009) 2.08
Endothelialized networks with a vascular geometry in microfabricated poly(dimethyl siloxane). Biomed Microdevices (2004) 1.97
Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials (2005) 1.93
Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol (2002) 1.92
Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation (2005) 1.90
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab (2005) 1.77
Enhanced in vivo function of bioartificial lungs in rats. Ann Thorac Surg (2011) 1.75
Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma. Arterioscler Thromb Vasc Biol (2008) 1.70
In vivo association between positive coronary artery remodelling and coronary plaque characteristics assessed by intravascular optical coherence tomography. Eur Heart J (2008) 1.69
High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood (2011) 1.68
Reporting trends and outcomes in ST-segment-elevation myocardial infarction national hospital quality assessment programs. Circulation (2013) 1.67
DRAGON: a member of the repulsive guidance molecule-related family of neuronal- and muscle-expressed membrane proteins is regulated by DRG11 and has neuronal adhesive properties. J Neurosci (2004) 1.64
Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg (2004) 1.64
Percutaneous mitral valve repair for chronic ischemic mitral regurgitation: a real-time three-dimensional echocardiographic study in an ovine model. Circulation (2005) 1.57
Impact of rapid ventricular pacing during percutaneous balloon aortic valvuloplasty in patients with critical aortic stenosis: should we be using it? Catheter Cardiovasc Interv (2010) 1.57
alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation (2005) 1.56
Assessment of nonstenotic coronary lesions by 64-slice multidetector computed tomography in comparison to intravascular ultrasound: evaluation of nonculprit coronary lesions. J Cardiovasc Comput Tomogr (2008) 1.55
Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation (2003) 1.55
Long-term experience and outcomes with transcatheter closure of patent foramen ovale. JACC Cardiovasc Interv (2013) 1.50
Reperfused myocardial infarction: contrast-enhanced 64-Section CT in comparison to MR imaging. Radiology (2008) 1.49
Three-Dimensional Microfluidic Tissue-Engineering Scaffolds Using a Flexible Biodegradable Polymer. Adv Mater (2005) 1.49
Microfabrication of three-dimensional engineered scaffolds. Tissue Eng (2007) 1.48
Engineered vascularized bone grafts. Proc Natl Acad Sci U S A (2010) 1.47
Tissue-engineered hybrid tooth and bone. Tissue Eng (2005) 1.46
Quantification of nonculprit coronary lesions: comparison of cardiac 64-MDCT and invasive coronary angiography. AJR Am J Roentgenol (2008) 1.45
High prevalence of respiratory ciliary dysfunction in congenital heart disease patients with heterotaxy. Circulation (2012) 1.44
Coronary stent assessability by 64 slice multi-detector computed tomography. Catheter Cardiovasc Interv (2007) 1.42
Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes. Catheter Cardiovasc Interv (2009) 1.40
Comprehensive assessment of myocardial perfusion defects, regional wall motion, and left ventricular function by using 64-section multidetector CT. Radiology (2008) 1.37
Hepatic tissue engineering. Transpl Immunol (2004) 1.36
The coronary venous anatomy: a segmental approach to aid cardiac resynchronization therapy. J Am Coll Cardiol (2005) 1.36
In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng (2004) 1.34
Assessment of coronary remodeling in stenotic and nonstenotic coronary atherosclerotic lesions by multidetector spiral computed tomography. J Am Coll Cardiol (2004) 1.30
Percutaneous transcatheter patent foramen ovale closure using the right internal jugular venous approach. Catheter Cardiovasc Interv (2003) 1.30
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A (2005) 1.24
Hydrogel-beta-TCP scaffolds and stem cells for tissue engineering bone. Bone (2005) 1.20
The tissue-engineered auricle: past, present, and future. Tissue Eng Part B Rev (2011) 1.20
Hemodynamic monitoring in obese patients: the impact of body mass index on cardiac output and stroke volume. Crit Care Med (2006) 1.18
Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med (2007) 1.18
Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. Transplantation (2002) 1.17
Tissue engineering auricular reconstruction: in vitro and in vivo studies. Biomaterials (2004) 1.17
Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am J Transplant (2004) 1.17
Tissue-engineered large intestine resembles native colon with appropriate in vitro physiology and architecture. Ann Surg (2003) 1.17
Venice Chart international consensus document on atrial fibrillation ablation: 2011 update. J Cardiovasc Electrophysiol (2012) 1.16
Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol (2003) 1.15
Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo. Clin Cancer Res (2002) 1.15
Compression of right ventricular out-flow due to localized hematoma after coronary perforation during PCI. Catheter Cardiovasc Interv (2003) 1.14
A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases. J Vasc Res (2002) 1.14
Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization. Nat Clin Pract Cardiovasc Med (2007) 1.14
Lung assist device technology with physiologic blood flow developed on a tissue engineered scaffold platform. Lab Chip (2010) 1.13
Reconstruction of mandibular defects with autologous tissue-engineered bone. J Oral Maxillofac Surg (2004) 1.13
Early and late clinical outcomes following coronary perforation in patients undergoing percutaneous coronary intervention. Circ J (2002) 1.12
Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation (2002) 1.10
Tissue-engineered esophagus: experimental substitution by onlay patch or interposition. J Thorac Cardiovasc Surg (2003) 1.08
Differentiation of recent and chronic myocardial infarction by cardiac computed tomography. Am J Cardiol (2006) 1.08
The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials (2008) 1.07
The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents. Catheter Cardiovasc Interv (2003) 1.07
Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1. Arterioscler Thromb Vasc Biol (2006) 1.05
Comparison of nonuniform rotational distortion between mechanical IVUS and OCT using a phantom model. Ultrasound Med Biol (2007) 1.04
Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. J Pediatr Surg (2006) 1.03
Engraftment of retroviral EGFP-transduced bone marrow in mice prevents rejection of EGFP-transgenic skin grafts. Mol Ther (2003) 1.03
Images in cardiovascular medicine. Visualization of endomyocardial fibrosis by delayed-enhancement magnetic resonance imaging. Circulation (2005) 1.02
Formation of a mandibular condyle in vitro by tissue engineering. J Oral Maxillofac Surg (2003) 1.01
Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine. Am J Physiol Gastrointest Liver Physiol (2003) 1.01
Survival and neurologic recovery in patients with ST-segment elevation myocardial infarction resuscitated from cardiac arrest. J Am Coll Cardiol (2009) 1.01
Engineering extracellular matrix through nanotechnology. J R Soc Interface (2010) 1.00
The retention of extracellular matrix proteins and angiogenic and mitogenic cytokines in a decellularized porcine dermis. Biomaterials (2010) 1.00
Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Rev (2009) 1.00
Engineering ear constructs with a composite scaffold to maintain dimensions. Tissue Eng Part A (2011) 0.99
Tissue engineering and organ structure: a vascularized approach to liver and lung. Pediatr Res (2008) 0.98
Prospects for tooth regeneration. Periodontol 2000 (2006) 0.98
Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention. J Am Heart Assoc (2013) 0.98
Toward regenerating a human thumb in situ. Tissue Eng Part A (2009) 0.97
Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng (2003) 0.96
Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine. Transplantation (2006) 0.96
Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy. Cancer Res (2002) 0.95